» Articles » PMID: 24148210

Familial Adenomatous Polyposis of the Colon

Overview
Publisher Biomed Central
Specialty Oncology
Date 2013 Oct 24
PMID 24148210
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Familial adenomatous polyposis (FAP) is a well-defined autosomal dominant predisposition to the development of polyposis in the colon and rectum at unusually early ages. The first symptoms of FAP are diarrhea and blood in the stool. Weight loss and weaknesses occur after the development of advanced tumour. The incidence of the FAP disorder is one per 10000 newborns. There are high levels of heterogeneity with regard to the number and timing of the occurrence of polyps. The classical form of FAP is characterized by the presence of more than 100 polyps, which appear in the second decade of life. The average time of occurrence of polyps is 15 years. The earliest symptoms of polyposis have been observed in a three-year-old child. The polyps are characterized by large potential for the development towards malignant tumour. Malignancy can occur from late childhood onwards. Attenuated adenomatous polyposis coli is characterized by a more benign course of disease in contrast to classical FAP. The occurrence of FAP is associated with mutations in the APC tumour suppressor gene, which was described in 1991. The APC gene is located on chromosome 5q21 and is involved in cell proliferation control. A recessive form of adenomatous polyposis is caused by mutations in the base excision repair gene - MUTYH gene. The MUTYH gene is involved in repairing DNA lesions as a result of oxidative DNA damage. MUTYH associated polyposis (MAP) is a predisposition to the development of polyps of the colon but the number of polyps is lower in comparison to classical FAP. The high risks of cancer observed in these two diseases make them important medical issues. Molecular studies of colonic polyposis have been performed in Poland for over fifteen years. A DNA Bank for Polish FAP patients was established at the Institute of Human Genetics in Poznan in which DNA samples from 600 FAP families have been collected.

Citing Articles

Tissue-Predisposition to Cancer Driver Mutations.

Peters L, Venkatachalam A, Ben-Neriah Y Cells. 2024; 13(2).

PMID: 38247798 PMC: 10814991. DOI: 10.3390/cells13020106.


Using of endoscopic polypectomy in patients with diagnosed malignant colorectal polyp - The cross-sectional clinical study.

Stojic V, Zdravkovic N, Nikolic-Turnic T, Zdravkovic N, Dimitrijevic J, Misic A Open Med (Wars). 2023; 18(1):20230811.

PMID: 37873541 PMC: 10590616. DOI: 10.1515/med-2023-0811.


Molecular Pathways of Carcinogenesis in Familial Adenomatous Polyposis.

Ditonno I, Novielli D, Celiberto F, Rizzi S, Rendina M, Ierardi E Int J Mol Sci. 2023; 24(6).

PMID: 36982759 PMC: 10056005. DOI: 10.3390/ijms24065687.


Strong Hereditary Predispositions to Colorectal Cancer.

Hryhorowicz S, Kaczmarek-Rys M, Lis-Tanas E, Porowski J, Szuman M, Grot N Genes (Basel). 2022; 13(12).

PMID: 36553592 PMC: 9777620. DOI: 10.3390/genes13122326.


The Mutation Spectrum and Two Novel Point Mutations in the APC Gene in Vietnamese Patients with Familial Adenomatous Polyposis.

Nguyen B, Nguyen S, Nguyen H, Nguyen T, Minh Le K Asian Pac J Cancer Prev. 2022; 23(5):1517-1522.

PMID: 35633533 PMC: 9587892. DOI: 10.31557/APJCP.2022.23.5.1517.


References
1.
Distante S, Nasioulas S, Somers G, Cameron D, Young M, Forrest S . Familial adenomatous polyposis in a 5 year old child: a clinical, pathological, and molecular genetic study. J Med Genet. 1996; 33(2):157-60. PMC: 1051844. DOI: 10.1136/jmg.33.2.157. View

2.
Plawski A, Podralska M, Slomski R . Recurrent APC gene mutations in Polish FAP families. Hered Cancer Clin Pract. 2009; 5(4):195-8. PMC: 2736979. DOI: 10.1186/1897-4287-5-4-195. View

3.
Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H . Identification and characterization of the familial adenomatous polyposis coli gene. Cell. 1991; 66(3):589-600. DOI: 10.1016/0092-8674(81)90021-0. View

4.
Itoh H, Ohsato K . Turcot syndrome and its characteristic colonic manifestations. Dis Colon Rectum. 1985; 28(6):399-402. DOI: 10.1007/BF02560221. View

5.
Fearon E, Vogelstein B . A genetic model for colorectal tumorigenesis. Cell. 1990; 61(5):759-67. DOI: 10.1016/0092-8674(90)90186-i. View